跳至主要内容
临床试验/ITMCTR2100005311
ITMCTR2100005311尚未招募1 期

Clinical Observation of Qingying powder Intervention in Hashimoto thyroiditis with normal thyroid function

Shanghai Municipal Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
20 至 65(—)
性别
All

入选标准

  • ? Comply with the diagnostic criteria of hashimoto's thyroiditis, TCM syndrome differentiation is liver spleen deficiency type;
  • ? Adult patients aged 20 to 65 years, both male or female;
  • ? Thyroid peroxidase antibody(TGAb) >300 IU/ml;
  • ? Triiodothyronine(T3), thyroxine(T4),thyroid-stimulating hormone(TSH) were normal;
  • ? Signing informed consent.

排除标准

  • ? Pregnant or lactating women;
  • ? Anemia (male: hemoglobin<120g/L, female: hemoglobin<110g/L);
  • ? Patients with autoimmune hepatitis, chronic glomerulonephritis and other autoimmune diseases;
  • ? Patients received drugs that may affect the conversion of thyroxine to triiodothyronine, may affect thyroid autoimmune drug therapy including corticosteroid, amiodaron, propranolol, a-interferon, etc;
  • ? Osteoporosis;
  • ? Patients with mental illness.

研究者

相似试验

Clinical Observation of Qingying powder Intervention... | 临床试验